What Nanoflex Robotics does

Nanoflex Robotics AG is a privately held Swiss MedTech company founded in 2021 as a spin-off of ETH Zurich's Multi-Scale Robotics Lab, headquartered in Glattbrugg (Opfikon), Switzerland. The company develops a telerobotic platform called the Remote Intervention System (RIS) for endovascular interventions, with initial application in mechanical thrombectomy for acute ischemic stroke. The platform comprises a compact mobile magnetic field generator, a robotic advancer system, a control console, and proprietary ultra-flexible magnetic guidewires. Physicians steer devices through the vasculature using electromagnetic fields rather than conventional torque-based control, enabling remote teleoperation across geographical barriers and reducing physician X-ray exposure. The platform also incorporates AI-compatible remote connectivity software and an AI-assisted navigation feature developed in collaboration with Brainomix.

The company's business model centers on direct sale of the capital hardware platform and proprietary consumable guidewires to hospitals with interventional neuroradiology and stroke treatment capabilities. A future software/services revenue stream is anticipated through licensing of AI-compatible connectivity features. Commercialization requires CE marking in Europe (in progress) and is supported by a regional partnership MOU with Genpharm for Gulf and Levant market entry. Clinical development has been validated through preclinical studies with Inselspital (Bern University Hospital) and University Hospital of Zurich, including a first-of-its-kind transatlantic remote thrombectomy procedure between the USA and Switzerland in May 2025.

Nanoflex has raised approximately USD 12M in seed funding (2023, led by Ascend Capital Partners), CHF 2.9M in non-dilutive Innosuisse grants (2023), and EUR 12.5M in blended EIC Accelerator financing (2026). The company holds ISO 13485:2016 certification, has been recognized consecutively in the TOP 100 Swiss Startup rankings, and won the ZKB Pionierpreis Technopark 2025 and Falling Walls Venture 2024 awards. Leadership combines academic robotics pedigree (Prof. Bradley Nelson, ETH Zurich) with commercial medtech and industrial robotics scaling experience (Matt Curran, ex-Medtronic; Per Vegard Nerseth, ex-CEO of CMR Surgical, ex-ABB Robotics).

Name

Nanoflex Robotics

Legal name

Nanoflex Robotics AG

Website

https://nanoflexrobotics.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Nanoflex Robotics AG is a Swiss MedTech company developing a magnetically controlled telerobotic platform for remote endovascular interventions, initially targeting mechanical thrombectomy for acute ischemic stroke in hospitals with interventional neuroradiology capabilities.

Ownership category

akta.pro rank

Product category

Endovascular Surgical Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Neurology Telemedicine Platforms (HLALAGAC), Stroke & Vascular Neurology (HLAKAIAG)

Keywords

• Magnetic navigation robotics
• Endovascular intervention systems
• Remote thrombectomy platform
• Telerobotic stroke treatment
• Medical microrobotic devices

Headquarters

HQ city

Opfikon

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Medical Device Hardware Sales: Sale of telerobotics platform including magnetic field generator, robotic advancer system, control interface console, and proprietary magnetic guidewires to hospitals for endovascular procedures.
2. Software/Services (Future): Potential software licensing and service components associated with the AI-compatible remote connectivity software and ongoing support for the platform.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Nanoflex Robotics develops a telerobotic platform (the Remote Intervention System) that uses magnetic fields to remotely steer ultra-flexible guidewires and catheters through blood vessels, enabling physicians to perform endovascular interventions from a distance. The initial clinical application is mechanical thrombectomy for acute ischemic stroke, with broader applicability to neurovascular, cardiovascular, and peripheral vascular procedures. The platform comprises a mobile magnetic field generator, robotic advancer system, control console, and proprietary magnetic guidewires, augmented by AI-compatible remote connectivity software.

Product overview

Nanoflex Robotics offers a unified telerobotics platform called the Remote Intervention System (RIS) for endovascular interventions. The system comprises a mobile magnetic field generator, robotic advancer system, and control interface that work together with proprietary magnetic guidewires to enable remote or bedside thrombectomies and other vascular procedures. An AI-assisted navigation feature developed with Brainomix adds artificial intelligence-powered imaging capabilities to enhance device navigation. The platform is designed primarily for acute ischemic stroke treatment but supports neurovascular, cardiovascular, and peripheral vascular applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Remote Intervention System (RIS) Telerobotic platform that enables physicians to perform endovascular interventions remotely using magnetic navigation, with initial application in mechanical thrombectomy for acute ischemic stroke. Targets hospitals with interventional neuroradiology and stroke centers.
• Magnetic Guidewires Proprietary ultra-flexible magnetic guidewires designed for use with the magnetic navigation system, enabling direct tip control via electromagnetic fields rather than conventional torque-based steering through complex vascular anatomy.

Quantifiable outcome

• 100% success rate in navigation and clot retrieval in preclinical animal studies including first transatlantic remote procedure
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Six partnerships are on record, tiered strategic and core.

• GenpharmstrategicStrategic or Co-development Partner · 9 June 2026Dubai-based specialty healthcare company and regional leader in rare disease and advanced therapy market access. MOU to explore collaboration across Gulf and Levant countries for regulatory strategy, market entry, clinical engagement, and commercial roll-out of Nanoflex's endovascular robotic platform.
• Inselspital (Bern University Hospital)coreStrategic or Co-development Partner · 14 May 2025Clinical research partner for preclinical studies including the first transatlantic remote animal thrombectomy between USA and Switzerland. Vascular surgeons and neuroradiologists from Inselspital collaborated on studies demonstrating the feasibility of the robotic platform.
• University Hospital of ZurichcoreStrategic or Co-development Partner · 14 May 2025Clinical partner for preclinical studies, including Dr. Tilman Schubert performing remote neuro-intervention procedures via teleoperation from University Hospital of Zurich to Inselspital in Bern.
• BrainomixcoreStrategic or Co-development Partner · 9 October 2023UK-based AI-powered medtech company. Joint project under UK-Switzerland Bilateral Collaborative R&D program to develop AI-assisted magnetic navigation system for robotic surgical tools, combining Brainomix's diagnostic imaging AI with Nanoflex's magnetic navigation technology.
• ETH ZurichcoreStrategic or Co-development PartnerSwiss Federal Institute of Technology - source of proprietary electromagnetic field technology based on 20+ years of research. Nanoflex Robotics was spun out from ETH Zurich in 2021.
• Wyss ZurichcoreStrategic or Co-development PartnerJoint accelerator of University of Zurich and ETH Zurich focused on regenerative medicine and robotics. Received ongoing support and incubation from Wyss Zurich since founding.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Stereotaxis: Stereotaxis develops magnetically guided robotic systems for endovascular interventions, most notably cardiac ablation and increasingly neurovascular applications. It is the closest direct competitor to Nanoflex, using a similar magnetic-navigation architecture and addressing the same class of endovascular procedures.
• Robocath: Robocath develops the R-One robotic platform for catheter-based vascular interventions, including coronary and neurovascular procedures. It is a direct peer in robotic endovascular intervention, though focused on mechanical rather than magnetic navigation and serving a similar hospital customer base.
• CMR Surgical: CMR Surgical develops the Versius surgical robotic system for laparoscopic procedures and is one of the closest non-incumbent surgical robotics peers. Its former CEO (Per Vegard Nerseth) sits on Nanoflex's board, providing direct insight into surgical robotics commercial scaling.

Broad incumbents

• Siemens Healthineers (Corindus): Siemens Healthineers acquired Corindus, whose CorPath GRX is a robotic platform for percutaneous coronary and peripheral vascular interventions. It is a broad incumbent competing in the same endovascular robotic category but with substantially more resources and a different mechanical (rather than magnetic) navigation approach.
• Penumbra: Penumbra is a leading player in mechanical thrombectomy for acute ischemic stroke with its aspiration and stent-retriever systems. It is a broad incumbent in Nanoflex's primary clinical indication (mechanical thrombectomy) and serves the same interventional neuroradiology hospital customers.
• Medtronic (Neurovascular & Hugo): Medtronic has a leading neurovascular portfolio (including coils, flow diverters, and stent retrievers for stroke) and is developing the Hugo robotic-assisted surgery platform. It is a broad incumbent with overlapping endovascular and robotic surgery ambitions, and Nanoflex's CEO is a former 20+ year Medtronic commercial executive.
• Intuitive Surgical: Intuitive Surgical is the dominant surgical robotics incumbent with the da Vinci platform and the emerging Ion and SP systems. While its current focus is laparoscopic and thoracic surgery rather than endovascular, it represents the largest competitive threat and benchmark for robotic surgery adoption and ecosystem control.
• MicroPort Scientific: MicroPort has a substantial endovascular and neurovascular portfolio (including stroke intervention devices) and operates globally. It is a broad incumbent in the same clinical category as Nanoflex's primary application, with established hospital relationships that could be a competitive moat or a partnership opportunity.

Emerging players

• RapidAI: RapidAI provides AI-driven neuroimaging analysis and workflow software for stroke triage and treatment decisions. It is an emerging player that complements rather than directly competes with Nanoflex's hardware, but it competes for the same hospital budget and clinical workflow in stroke care, similar to Nanoflex's Brainomix partnership.
• Viz.ai: Viz.ai is an AI care coordination platform that speeds triage of suspected stroke patients to thrombectomy-capable centers. It is an emerging player addressing the same clinical workflow but as a software layer rather than a robotic platform, and represents both a potential partner and a competitor for the "remote stroke" thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nanoflex-robotics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanoflex Robotics